A new weight loss drug maybe harmful for mothers to be
Rimonabant is a new weight loss drug that may pose risks for mothers to be.
A new study performed at the Vanderbilt University Medical Center in Nashville, has concluded that certain weight loss drugs maybe harmful to mothers-to-be. Rimonabant is the name of a weight loss drug that according to researchers can interfere with the ability of embryos to properly implant themselves in the womb of a woman.
Anandamide is the name of the needed chemical that aids in the implantation of an embryo and according to researchers, even a slight change in the amount of this chemical can lessen a woman's chance of becoming pregnant.
The research study can be found in the Journal of Clinical Investigation.
Related Articles: Diabetes Drug Controls Glucose, Aids Weight Loss | French Wonder Weight Loss Pill | New Zealand To Evaluate Latest Weight-Loss Drug
